Regenerative medicine company Regenity Biosciences has received 510(k) clearance from the US Food and Drug Administration (FDA) for its RejuvaKnee meniscus implant. This device is designed to ...
MEMPHIS, Tenn.--(BUSINESS WIRE)--Active Implants, LLC, a developer of orthopedic implant solutions for joint preservation, today announced two-year results of the MERCURY study, which showed that the ...
DUBLIN, Feb. 11, 2020 /PRNewswire/ -- The "Global Collagen Meniscus Implant Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and ...
The bio-inspired implant could help patients avoid total knee replacements, which are frequently required due to long-term degeneration caused by meniscus injuries. Jonathan Schwartz, OrthoPreserve's ...
BOSTON (CBS) -- Americans of all ages suffer from chronic knee pain due to meniscus injuries. Most are too young to have replacement surgery, but there aren't a lot of other options. "I couldn't get ...
Regenity Biosciences said it has received FDA clearance to begin marketing RejuvaKnee, what it's calling a minimally invasive collagen-based meniscal implant designed to help with the reinforcement ...
BATON ROUGE, LA (WAFB) - It's one of the most common knee problems in the world. As many as 700,000 procedures are done in the U.S. every year to repair a torn meniscus, and oftentimes the patient ...
Wayne K. Gersoff, MD, who presented the findings at the American Orthopaedic Society for Sports Medicine and Arthroscopy Association of North America Combined Meeting, here, said the data for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback